{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T12:19:21Z","timestamp":1762604361706,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.neuroscience.2022.11.026","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T06:58:50Z","timestamp":1669359530000},"page":"125-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Transdermal Application of Soluble CuII(atsm) Increases Brain and Spinal Cord Uptake Compared to Gavage with an Insoluble Suspension"],"prefix":"10.1016","volume":"509","author":[{"given":"Sara","family":"Nikseresht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.W.","family":"Hilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey R.","family":"Liddell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Kysenius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley I.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Ayton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HuiJing","family":"Koay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul S.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Crouch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2022.11.026_b0005","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0883-2897(92)90104-7","article-title":"Subcellular distribution of tissue radiocopper following intravenous administration of 67Cu-labeled Cu-PTSM","volume":"19","author":"Baerga","year":"1992","journal-title":"Int J Rad Appl Instrum B"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0010","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1039\/B307499D","article-title":"Structural trends in copper(II) bis(thiosemicarbazone) radiopharmaceuticals","volume":"23","author":"Blower","year":"2003","journal-title":"Dalton Transactions"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/BJ20070579","article-title":"Differential modulation of Alzheimer's disease amyloid beta peptide accumulation by diverse classes of metal ligands","volume":"407","author":"Caragounis","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0020","doi-asserted-by":"crossref","first-page":"22398","DOI":"10.1038\/srep22398","article-title":"Gene dysregulation is restored in the Parkinson's disease MPTP neurotoxic mice model upon treatment of the therapeutic drug Cu(II)(atsm)","volume":"6","author":"Cheng","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0025","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3389\/fnins.2018.00668","article-title":"CuII(atsm) attenuates neuroinflammation","volume":"12","author":"Choo","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1073\/pnas.0809057106","article-title":"Increasing Cu bioavailability inhibits A\u03b2 oligomers and tau phosphorylation","volume":"106","author":"Crouch","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0035","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1039\/a805957h","article-title":"Redox-active metal complexes for imaging hypoxic tissues: Structure activity relationships in copper(II) bis(thiosemicarbazone) complexes","author":"Dearling","year":"1998","journal-title":"Chem Commun"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0040","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s002590050283","article-title":"Design of hypoxia-targeting radiopharmaceuticals: selective uptake of copper-64 complexes in hypoxic cells in vitro","volume":"25","author":"Dearling","year":"1998","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0045","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s007750100291","article-title":"Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships","volume":"7","author":"Dearling","year":"2002","journal-title":"J Biol Inorg Chem"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0050","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1074\/jbc.M705957200","article-title":"Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-\u03b2 peptide","volume":"283","author":"Donnelly","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1073\/pnas.1116227108","article-title":"An impaired mitochondrial electron transport chain increases retention of the hypoxia imaging agent diacetylbis(4-methylthiosemicarbazonato)copperII","volume":"109","author":"Donnelly","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JAD-2010-1359","article-title":"Bis(thiosemicarbazonato) Cu-64 complexes for positron emission tomography imaging of Alzheimer's disease","volume":"20","author":"Fodero-Tavoletti","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0065","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1139\/v62-161","article-title":"The preparation of some thiosemicarbazones and their copper complexes: Part III","volume":"40","author":"Gingras","year":"1962","journal-title":"Can J Chem"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0070","first-page":"42292","article-title":"CuII(atsm) improves the neurological phenotype and survival of SOD1G93A mice and selectively increases enzymatically active SOD1 in the spinal cord","volume":"7","author":"Hilton","year":"2017","journal-title":"Sci Reports"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0075","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1084\/jem.20112285","article-title":"The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease","volume":"209","author":"Hung","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0080","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s13311-016-0504-9","article-title":"The copper bis(thiosemicarbazone) complex CuII(atsm) is protective against cerebral ischemia through modulation of the inflammatory milieu","volume":"14","author":"Huuskonen","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0085","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.mito.2009.01.011","article-title":"PET imaging of redox and energy states in stroke-like episodes of MELAS","volume":"9","author":"Ikawa","year":"2009","journal-title":"Mitochondrion"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0090","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.nucmedbio.2011.02.016","article-title":"Evaluation of striatal oxidative stress in patients with Parkinson's disease using [62Cu]ATSM PET","volume":"38","author":"Ikawa","year":"2011","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0095","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1212\/WNL.0000000000001588","article-title":"Increased oxidative stress is related to disease severity in the ALS motor cortex: A PET study","volume":"84","author":"Ikawa","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0100","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104495","article-title":"Neuroprotective effect of CuATSM on neurotoxin-induced motor neuron loss in an ALS mouse model","volume":"130","author":"Kuo","year":"2019","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102424","article-title":"Mitochondrial and redox modifications in early stages of Huntington's disease","volume":"56","author":"Lopes","year":"2022","journal-title":"Redox Biol"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0115","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0022-3565(25)28988-1","article-title":"The route of absorption of intraperitoneally administered compounds","volume":"178","author":"Lukas","year":"1971","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0120","doi-asserted-by":"crossref","first-page":"19392","DOI":"10.1038\/s41598-021-98317-w","article-title":"CuATSM improves motor function and extends survival but is not tolerated at a high dose in SOD1(G93A) mice with a C57BL\/6 background","volume":"11","author":"Lum","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0125","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/21678421.2013.824000","article-title":"Therapeutic effects of CuII(atsm) in the SOD1G37R mouse model of amyotrophic lateral sclerosis","volume":"14","author":"McAllum","year":"2013","journal-title":"Amyotrophic Lateral Sclerosis Frontotemp Degener"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0130","first-page":"117","article-title":"Initial reaction of 3-ethyoxy-2-oxobutyraldehyde bis(thiosemicarbazonato) copper(II) with Ehrlich ascites tumor cells","volume":"38","author":"Minkel","year":"1978","journal-title":"Cancer Res"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0135","first-page":"124","article-title":"Structure-function correlations in the reaction of bis(thiosemicarbazonato) copper(II) complexes with Ehrlich ascites tumor cells","volume":"38","author":"Minkel","year":"1978","journal-title":"Cancer Res"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0140","unstructured":"NCT02870634. ClinicalTrials.org study # NCT02870634 \u201cPhase 1 dose escalation and PK study of Cu(II)ATSM in ALS\/MND\u201d."},{"key":"10.1016\/j.neuroscience.2022.11.026_b0145","unstructured":"NCT03136809. ClinicalTrials.org study # NCT03136809 \u201cALS Treatment Extension Study\u201d."},{"key":"10.1016\/j.neuroscience.2022.11.026_b0150","unstructured":"NCT03204929. ClinicalTrials.org study # NCT03204929 \u201cDose Escalation Study of Cu(II)ATSM in Parkinson's Disease\u201d."},{"key":"10.1016\/j.neuroscience.2022.11.026_b0155","unstructured":"NCT04082832. ClinicalTrials.org study # NCT04082832 \u201cCuATSM compared with placebo for treatment of ALS\/MND\u201d."},{"key":"10.1016\/j.neuroscience.2022.11.026_b0160","unstructured":"NCT04313166. ClinicalTrials.org study # NCT04313166 \u201cTreatment Continuation Study for Patients With ALS\/MND Who Completed Study CMD-2019-001\u201d."},{"key":"10.1016\/j.neuroscience.2022.11.026_b0165","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fneur.2017.00094","article-title":"Dysphagia in amyotrophic lateral sclerosis: impact on patient behavior, diet adaptation, and riluzole management","volume":"8","author":"Onesti","year":"2017","journal-title":"Front Neurol"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0170","doi-asserted-by":"crossref","first-page":"9594","DOI":"10.1021\/ic201334q","article-title":"Mechanisms controlling the cellular accumulation of copper bis(thiosemicarbazonato) complexes","volume":"50","author":"Price","year":"2011","journal-title":"Inorg Chem"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0175","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0733-8619(18)30924-1","article-title":"Swallowing in ALS and motor neuron disorders","volume":"5","author":"Robbins","year":"1987","journal-title":"Neurol Clin"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0180","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1523\/JNEUROSCI.4196-13.2014","article-title":"Oral treatment with CuII(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis","volume":"34","author":"Roberts","year":"2014","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0185","doi-asserted-by":"crossref","first-page":"44035","DOI":"10.1074\/jbc.M111.274407","article-title":"Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse model","volume":"286","author":"Soon","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0190","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ibror.2017.03.001","article-title":"CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits","volume":"2","author":"Vieira","year":"2017","journal-title":"IBRO Rep"},{"key":"10.1016\/j.neuroscience.2022.11.026_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2016.01.020","article-title":"Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SOD mice co-expressing the Copper-Chaperone-for-SOD","volume":"89","author":"Williams","year":"2016","journal-title":"Neurobiol Dis"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452222005826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452222005826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:16:11Z","timestamp":1759680971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452222005826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":39,"alternative-id":["S0306452222005826"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2022.11.026","relation":{},"ISSN":["0306-4522"],"issn-type":[{"type":"print","value":"0306-4522"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transdermal Application of Soluble CuII(atsm) Increases Brain and Spinal Cord Uptake Compared to Gavage with an Insoluble Suspension","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2022.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}